Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.55 |
| ▸ | NPY1R | P25929 | 9/20 | 0.55 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.55 |
| ▸ | NPY2R | P49146 | 5/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.52 |
| ▸ | TFPI | P10646 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7785393 | 0.96 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL7785397 | 0.96 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL31670482 | 0.95 | NPY4R (0.62) | NPY4RNPY1RNPY5RNPY2RKEAP1 | |
| SCHEMBL31410668 | 0.93 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RKEAP1 | |
| SCHEMBL29590465 | 0.93 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL30866943 | 0.93 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29568582 | 0.92 | NPY4R (0.60) | NPY4RNPY1RNPY5RNPY2RKEAP1 | |
| SCHEMBL31256690 | 0.92 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2RKEAP1 | |
| SCHEMBL31461918 | 0.91 | OPRM1 (0.54) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL30544262 | 0.91 | FOLH1 (0.53) | NPY4RNPY1RNPY5RNPY2RKEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250332261-A1 | Payload-Polymer-Protein Conjugates | GLYKOS FINLAND OY (FI) | 2025-10-30 | — | — | US | disclosed |
| EP-3166638-B1 | PAYLOAD-POLYMER-PROTEIN CONJUGATES | GLYKOS FINLAND OY (FI) | 2025-08-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332261-A1 | Payload-Polymer-Protein Conjugates | TXLNA, DDOST, CD44 | NPY4R 2312/4885NPY1R 1491/4885NPY5R 1876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.